Scopus subject area
Best Oncology journals
428 Scopus-active journals are ranked in Oncology. All are listed below, ranked by CiteScore percentile — 107 of them sit in quartile Q1. Every title links to a full profile with Scopus, Web of Science, ABDC, DOAJ and open-access details.
| # | Journal | CiteScore | Percentile | Quartile | WoS | ABDC | OA |
|---|---|---|---|---|---|---|---|
| 1 | Ca-A Cancer Journal for Clinicians | 649.8 | 99th | Q1 | SCIE | – | No |
| 2 | Nature Reviews Clinical Oncology | 126.6 | 99th | Q1 | SCIE | – | No |
| 3 | Nature Reviews Cancer | 96.2 | 99th | Q1 | SCIE | – | No |
| 4 | Cancer Cell | 75.4 | 99th | Q1 | SCIE | – | No |
| 5 | Journal of Hematology and Oncology | 70.1 | 98th | Q1 | SCIE | – | Yes |
| 6 | Annals of Oncology | 69.6 | 98th | Q1 | SCIE | – | No |
| 7 | Molecular Cancer | 55 | 98th | Q1 | SCIE | – | Yes |
| 8 | The Lancet Oncology | 42 | 98th | Q1 | SCIE | – | No |
| 9 | Cancer Communications | 40.3 | 98th | Q1 | SCIE | – | Yes |
| 10 | Nature Cancer | 38.5 | 97th | Q1 | SCIE | – | No |
| 11 | Journal of Thoracic Oncology | 33.4 | 97th | Q1 | SCIE | – | No |
| 12 | JAMA Oncology | 32.6 | 97th | Q1 | SCIE | – | No |
| 13 | Journal of the National Cancer Center | 31.2 | 97th | Q1 | ESCI | – | Yes |
| 14 | Trends in Cancer | 30.8 | 96th | Q1 | SCIE | – | No |
| 15 | Drug Resistance Updates | 29.1 | 96th | Q1 | SCIE | – | No |
| 16 | Cancer Discovery | 26.9 | 96th | Q1 | SCIE | – | No |
| 17 | Journal of Experimental and Clinical Cancer Research | 22.3 | 96th | Q1 | SCIE | – | Yes |
| 18 | Neuro-Oncology | 21.1 | 95th | Q1 | SCIE | – | No |
| 19 | The Lancet Regional Health - Europe | 19.9 | 95th | Q1 | SCIE, SSCI | – | Yes |
| 20 | Experimental Hematology and Oncology | 19.6 | 95th | Q1 | SCIE | – | Yes |
| 21 | JNCCN Journal of the National Comprehensive Cancer Network | 19.4 | 95th | Q1 | SCIE | – | No |
| 22 | Leukemia | 19.2 | 94th | Q1 | SCIE | – | No |
| 23 | Cancer Treatment Reviews | 17.7 | 94th | Q1 | SCIE | – | No |
| 24 | Clinical Cancer Research | 17.3 | 94th | Q1 | SCIE | – | No |
| 25 | Cancer Research | 17 | 94th | Q1 | SCIE | – | No |
| 26 | Liver Cancer | 17 | 94th | Q1 | SCIE | – | Yes |
| 27 | Journal for ImmunoTherapy of Cancer | 16.6 | 93rd | Q1 | SCIE | – | Yes |
| 28 | Cancer and Metastasis Reviews | 16.3 | 93rd | Q1 | SCIE | – | No |
| 29 | JACC: CardioOncology | 16.3 | 93rd | Q1 | SCIE | – | Yes |
| 30 | Blood Cancer Journal | 16.2 | 93rd | Q1 | SCIE | – | Yes |
| 31 | Cancer Letters | 15.4 | 92nd | Q1 | SCIE | – | No |
| 32 | Journal of Clinical Oncology | 14.2 | 92nd | Q1 | SCIE | – | No |
| 33 | Biochimica et Biophysica Acta - Reviews on Cancer | 14.1 | 92nd | Q1 | SCIE | – | No |
| 34 | British Journal of Cancer | 13.9 | 92nd | Q1 | SCIE | – | No |
| 35 | Blood Cancer Discovery | 13.9 | 91st | Q1 | ESCI | – | No |
| 36 | Blood Reviews | 12.7 | 91st | Q1 | SCIE | – | No |
| 37 | Breast | 12.6 | 91st | Q1 | SCIE | – | Yes |
| 38 | MedComm | 12.5 | 91st | Q1 | ESCI | – | Yes |
| 39 | npj Breast Cancer | 12.4 | 91st | Q1 | SCIE | – | Yes |
| 40 | Journal of the National Cancer Institute | 12.3 | 90th | Q1 | SCIE | – | No |
| 41 | OncoImmunology | 12.1 | 90th | Q1 | SCIE | – | Yes |
| 42 | ESMO Open | 12 | 90th | Q1 | SCIE | – | Yes |
| 43 | Experientia Supplementum (2012) | 12 | 90th | Q1 | – | – | No |
| 44 | Prostate Cancer and Prostatic Diseases | 11.9 | 89th | Q1 | SCIE | – | No |
| 45 | Gastric Cancer | 11.8 | 89th | Q1 | SCIE | – | No |
| 46 | Cancer Biology and Medicine | 11.5 | 89th | Q1 | SCIE | – | Yes |
| 47 | European Journal of Cancer | 10.9 | 89th | Q1 | SCIE | – | No |
| 48 | European Urology Oncology | 10.7 | 88th | Q1 | SCIE | – | No |
| 49 | Cancer | 10.6 | 88th | Q1 | SCIE | – | No |
| 50 | Cancer Cell International | 10.5 | 88th | Q1 | SCIE | – | Yes |
| 51 | International Journal of Oncology | 10.2 | 88th | Q1 | SCIE | – | No |
| 52 | International Journal of Radiation Oncology Biology Physics | 10.1 | 87th | Q1 | SCIE | – | No |
| 53 | Annual Review of Cancer Biology | 10 | 87th | Q1 | SCIE | – | No |
| 54 | Current Oncology Reports | 9.8 | 87th | Q1 | SCIE | – | No |
| 55 | npj Precision Oncology | 9.8 | 87th | Q1 | SCIE | – | Yes |
| 56 | International Journal of Cancer | 9.7 | 87th | Q1 | SCIE | – | No |
| 57 | Molecular Cancer Research | 9.6 | 86th | Q1 | SCIE | – | No |
| 58 | Molecular Therapy Oncology | 9.6 | 86th | Q1 | SCIE | – | Yes |
| 59 | Critical Reviews in Oncology/Hematology | 9.5 | 86th | Q1 | SCIE | – | No |
| 60 | Molecular Cancer Therapeutics | 9.5 | 86th | Q1 | SCIE | – | No |
| 61 | Cancer Immunology, Immunotherapy | 9.5 | 85th | Q1 | SCIE | – | Yes |
| 62 | Molecular Oncology | 9.4 | 85th | Q1 | SCIE | – | Yes |
| 63 | Current Treatment Options in Oncology | 9.3 | 85th | Q1 | SCIE | – | No |
| 64 | United European Gastroenterology Journal | 9.2 | 85th | Q1 | SCIE | – | No |
| 65 | Cancer Nanotechnology | 9.1 | 84th | Q1 | SCIE | – | Yes |
| 66 | Radiotherapy and Oncology | 9.1 | 84th | Q1 | SCIE | – | No |
| 67 | Cancers | 9 | 84th | Q1 | SCIE | – | Yes |
| 68 | Cancer Science | 8.9 | 84th | Q1 | SCIE | – | Yes |
| 69 | Cellular Oncology | 8.6 | 83rd | Q1 | SCIE | – | Yes |
| 70 | Immuno-Oncology and Technology | 8.6 | 83rd | Q1 | – | – | Yes |
| 71 | Journal of Cancer Survivorship | 8.6 | 83rd | Q1 | SCIE, SSCI | – | No |
| 72 | Cancer Biology and Therapy | 8.4 | 83rd | Q1 | SCIE | – | Yes |
| 73 | Breast Cancer Research | 8.1 | 83rd | Q1 | SCIE | – | Yes |
| 74 | Chinese Journal of Cancer Research | 7.9 | 82nd | Q1 | SCIE | – | No |
| 75 | Journal of Gastric Cancer | 7.8 | 82nd | Q1 | SCIE | – | No |
| 76 | Cancer Research and Treatment | 7.7 | 82nd | Q1 | SCIE | – | Yes |
| 77 | Oncology Reports | 7.7 | 82nd | Q1 | SCIE | – | No |
| 78 | Clinical and Experimental Metastasis | 7.4 | 81st | Q1 | SCIE | – | No |
| 79 | Lung Cancer | 7.4 | 81st | Q1 | SCIE | – | No |
| 80 | Molecular Medicine Reports | 7.3 | 81st | Q1 | SCIE | – | No |
| 81 | Translational Oncology | 7.3 | 81st | Q1 | SCIE | – | Yes |
| 82 | Gynecologic Oncology | 7.3 | 80th | Q1 | SCIE | – | No |
| 83 | Endocrine-Related Cancer | 7.2 | 80th | Q1 | SCIE | – | No |
| 84 | Advances in Cancer Research | 7 | 80th | Q1 | – | – | No |
| 85 | Targeted Oncology | 6.9 | 80th | Q1 | SCIE | – | No |
| 86 | Oncologist | 6.8 | 80th | Q1 | SCIE | – | Yes |
| 87 | Journal of Liver Cancer | 6.7 | 79th | Q1 | ESCI | – | Yes |
| 88 | Journal of Ovarian Research | 6.7 | 79th | Q1 | SCIE | – | Yes |
| 89 | Current Hematologic Malignancy Reports | 6.6 | 79th | Q1 | SCIE | – | No |
| 90 | Frontiers in Oncology | 6.6 | 79th | Q1 | SCIE | – | Yes |
| 91 | Journal of Mammary Gland Biology and Neoplasia | 6.5 | 78th | Q1 | SCIE | – | No |
| 92 | Oral Oncology | 6.5 | 78th | Q1 | SCIE | – | No |
| 93 | Cytotherapy | 6.4 | 78th | Q1 | SCIE | – | No |
| 94 | Seminars in Radiation Oncology | 6.4 | 78th | Q1 | SCIE | – | No |
| 95 | Head and Neck Pathology | 6.4 | 77th | Q1 | ESCI | – | No |
| 96 | JCO Oncology Practice | 6.4 | 77th | Q1 | SCIE | – | No |
| 97 | Journal of Cancer Research and Clinical Oncology | 6.4 | 77th | Q1 | SCIE | – | Yes |
| 98 | JTO Clinical and Research Reports | 6.3 | 77th | Q1 | ESCI | – | Yes |
| 99 | Cancer Pathogenesis and Therapy | 6.2 | 76th | Q1 | ESCI | – | Yes |
| 100 | Clinical Lung Cancer | 6.2 | 76th | Q1 | SCIE | – | No |
| 101 | International Journal of Gynecological Cancer | 6.2 | 76th | Q1 | SCIE | – | No |
| 102 | Nutrition and Cancer | 6.2 | 76th | Q1 | SCIE | – | No |
| 103 | Therapeutic Advances in Medical Oncology | 6.2 | 76th | Q1 | SCIE | – | Yes |
| 104 | BMJ Oncology | 6.2 | 75th | Q1 | ESCI | – | Yes |
| 105 | JCO Precision Oncology | 6.2 | 75th | Q1 | SCIE | – | No |
| 106 | Cancer Cytopathology | 6.1 | 75th | Q1 | SCIE | – | No |
| 107 | Current Oncology | 6.1 | 75th | Q1 | SCIE | – | Yes |
| 108 | Breast Cancer Research and Treatment | 6.1 | 74th | Q2 | SCIE | – | No |
| 109 | Cancer Nursing | 6 | 74th | Q2 | SCIE, SSCI | – | No |
| 110 | JNCI Cancer Spectrum | 6 | 74th | Q2 | ESCI | – | Yes |
| 111 | Therapeutic Advances in Vaccines and Immunotherapy | 6 | 74th | Q2 | – | – | Yes |
| 112 | Cancer Imaging | 5.9 | 73rd | Q2 | SCIE | – | Yes |
| 113 | Medical Oncology | 5.9 | 73rd | Q2 | SCIE | – | No |
| 114 | NAR Cancer | 5.9 | 73rd | Q2 | ESCI | – | Yes |
| 115 | Neuro-Oncology Advances | 5.9 | 73rd | Q2 | ESCI | – | Yes |
| 116 | Open Forum Infectious Diseases | 5.9 | 73rd | Q2 | SCIE | – | Yes |
| 117 | Cancer Biotherapy and Radiopharmaceuticals | 5.9 | 72nd | Q2 | SCIE | – | No |
| 118 | Radiation Oncology | 5.9 | 72nd | Q2 | SCIE | – | Yes |
| 119 | Journal of Bone Oncology | 5.8 | 72nd | Q2 | SCIE | – | Yes |
| 120 | Psycho-Oncology | 5.8 | 72nd | Q2 | SCIE, SSCI | – | No |
| 121 | Current Opinion in HIV and AIDS | 5.8 | 71st | Q2 | SCIE | – | No |
| 122 | Investigational New Drugs | 5.8 | 71st | Q2 | SCIE | – | No |
| 123 | Journal of Gynecologic Oncology | 5.8 | 71st | Q2 | SCIE | – | Yes |
| 124 | Practical Radiation Oncology | 5.8 | 71st | Q2 | SCIE | – | No |
| 125 | BMC Cancer | 5.7 | 70th | Q2 | SCIE | – | Yes |
| 126 | Cancer Medicine | 5.7 | 70th | Q2 | SCIE | – | Yes |
| 127 | Clinical and Translational Radiation Oncology | 5.7 | 70th | Q2 | SCIE | – | Yes |
| 128 | Hematology/Oncology Clinics of North America | 5.7 | 70th | Q2 | SCIE | – | No |
| 129 | Journal of Cancer | 5.6 | 69th | Q2 | SCIE | – | Yes |
| 130 | Photodiagnosis and Photodynamic Therapy | 5.6 | 69th | Q2 | SCIE | – | Yes |
| 131 | Recent Patents on Anti-Cancer Drug Discovery | 5.6 | 69th | Q2 | SCIE | – | No |
| 132 | Clinical Colorectal Cancer | 5.5 | 69th | Q2 | SCIE | – | No |
| 133 | Molecular Imaging and Biology | 5.5 | 69th | Q2 | SCIE | – | No |
| 134 | Current Research in Translational Medicine | 5.5 | 68th | Q2 | SCIE | – | No |
| 135 | Journal of Neuro-Oncology | 5.5 | 68th | Q2 | SCIE | – | No |
| 136 | Cancer Research Communications | 5.4 | 68th | Q2 | ESCI | – | Yes |
| 137 | Infectious Agents and Cancer | 5.4 | 68th | Q2 | SCIE | – | Yes |
| 138 | Breast Cancer | 5.4 | 67th | Q2 | SCIE | – | No |
| 139 | Cancer Epidemiology Biomarkers and Prevention | 5.4 | 67th | Q2 | SCIE | – | No |
| 140 | Exploration of Targeted Anti-tumor Therapy | 5.4 | 67th | Q2 | – | – | Yes |
| 141 | Oncotarget | 5.4 | 67th | Q2 | – | – | No |
| 142 | Clinical and Translational Oncology | 5.4 | 66th | Q2 | SCIE | – | No |
| 143 | Computational and Systems Oncology | 5.3 | 66th | Q2 | – | – | Yes |
| 144 | MedComm - Oncology | 5.3 | 66th | Q2 | ESCI | – | Yes |
| 145 | Supportive Care in Cancer | 5.3 | 66th | Q2 | SCIE | – | No |
| 146 | Technology in Cancer Research and Treatment | 5.2 | 66th | Q2 | SCIE | – | Yes |
| 147 | Hematological Oncology | 5.2 | 65th | Q2 | SCIE | – | No |
| 148 | Thoracic Cancer | 5.2 | 65th | Q2 | SCIE | – | Yes |
| 149 | Journal of Immunotherapy and Precision Oncology | 5.1 | 65th | Q2 | ESCI | – | Yes |
| 150 | Pigment Cell and Melanoma Research | 5.1 | 65th | Q2 | SCIE | – | No |
| 151 | Clinical Oncology | 5.1 | 64th | Q2 | SCIE | – | No |
| 152 | European Journal of Surgical Oncology | 5.1 | 64th | Q2 | SCIE | – | No |
| 153 | Integrative Cancer Therapies | 5.1 | 64th | Q2 | SCIE | – | Yes |
| 154 | Prostate | 5.1 | 64th | Q2 | SCIE | – | No |
| 155 | Breast Cancer: Targets and Therapy | 5 | 63rd | Q2 | SCIE | – | Yes |
| 156 | Cancer Treatment and Research Communications | 5 | 63rd | Q2 | ESCI | – | Yes |
| 157 | Oncology Reviews | 5 | 63rd | Q2 | ESCI | – | Yes |
| 158 | Pathology and Oncology Research | 5 | 63rd | Q2 | SCIE | – | Yes |
| 159 | Cancer Informatics | 4.9 | 62nd | Q2 | ESCI | – | Yes |
| 160 | Clinical Breast Cancer | 4.9 | 62nd | Q2 | SCIE | – | No |
| 161 | Expert Review of Anticancer Therapy | 4.9 | 62nd | Q2 | SCIE | – | No |
| 162 | Future Oncology | 4.9 | 62nd | Q2 | SCIE | – | No |
| 163 | Seminars in Oncology | 4.9 | 62nd | Q2 | SCIE | – | No |
| 164 | Cancer Prevention Research | 4.9 | 61st | Q2 | SCIE | – | No |
| 165 | International Journal of Clinical Oncology | 4.8 | 61st | Q2 | SCIE | – | No |
| 166 | JCO Clinical Cancer Informatics | 4.8 | 61st | Q2 | ESCI | – | No |
| 167 | Radiology: Imaging Cancer | 4.8 | 61st | Q2 | ESCI | – | No |
| 168 | Best Practice and Research: Clinical Haematology | 4.8 | 60th | Q2 | SCIE | – | No |
| 169 | Current Opinion in Oncology | 4.8 | 60th | Q2 | SCIE | – | No |
| 170 | Neoplasma | 4.8 | 60th | Q2 | SCIE | – | No |
| 171 | Precision Radiation Oncology | 4.8 | 60th | Q2 | ESCI | – | Yes |
| 172 | Cancer Journal (United States) | 4.7 | 59th | Q2 | SCIE | – | No |
| 173 | European Journal of Cancer Prevention | 4.7 | 59th | Q2 | SCIE | – | No |
| 174 | Journal of Breast Cancer | 4.7 | 59th | Q2 | SCIE | – | Yes |
| 175 | OncoTargets and Therapy | 4.7 | 59th | Q2 | SCIE | – | Yes |
| 176 | Annals of Surgical Oncology | 4.7 | 58th | Q2 | SCIE | – | No |
| 177 | Current Problems in Cancer | 4.7 | 58th | Q2 | SCIE | – | No |
| 178 | Surgical Oncology | 4.7 | 58th | Q2 | SCIE | – | No |
| 179 | Surgical Oncology Clinics of North America | 4.7 | 58th | Q2 | SCIE | – | No |
| 180 | Cancer Chemotherapy and Pharmacology | 4.6 | 58th | Q2 | SCIE | – | No |
| 181 | Anti-Cancer Drugs | 4.6 | 57th | Q2 | SCIE | – | No |
| 182 | Cancer Epidemiology | 4.6 | 57th | Q2 | SCIE | – | No |
| 183 | Translational Lung Cancer Research | 4.6 | 57th | Q2 | SCIE | – | Yes |
| 184 | Urologic Oncology: Seminars and Original Investigations | 4.6 | 57th | Q2 | SCIE | – | No |
| 185 | Biologics: Targets and Therapy | 4.5 | 56th | Q2 | ESCI | – | Yes |
| 186 | Brain Tumor Pathology | 4.5 | 56th | Q2 | SCIE | – | No |
| 187 | Innovation Medicine | 4.5 | 56th | Q2 | – | – | Yes |
| 188 | Lung Cancer: Targets and Therapy | 4.5 | 56th | Q2 | ESCI | – | Yes |
| 189 | Aging and Cancer | 4.4 | 55th | Q2 | – | – | Yes |
| 190 | Cancer Innovation | 4.4 | 55th | Q2 | ESCI | – | Yes |
| 191 | Cancer Management and Research | 4.4 | 55th | Q2 | SCIE | – | Yes |
| 192 | European Journal of Cancer Care | 4.4 | 55th | Q2 | SCIE, SSCI | – | No |
| 193 | Journal of Geriatric Oncology | 4.4 | 55th | Q2 | SCIE | – | No |
| 194 | Neuro-Oncology Practice | 4.4 | 54th | Q2 | ESCI | – | No |
| 195 | Oncology and Therapy | 4.4 | 54th | Q2 | ESCI | – | Yes |
| 196 | Physics and Imaging in Radiation Oncology | 4.4 | 54th | Q2 | ESCI | – | Yes |
| 197 | Strahlentherapie und Onkologie | 4.3 | 54th | Q2 | SCIE | – | No |
| 198 | Cancer Biomarkers | 4.3 | 53rd | Q2 | SCIE | – | No |
| 199 | JCO Global Oncology | 4.3 | 53rd | Q2 | ESCI | – | Yes |
| 200 | Sarcoma | 4.3 | 53rd | Q2 | – | – | No |
| 201 | World Journal of Surgical Oncology | 4.3 | 53rd | Q2 | SCIE | – | Yes |
| 202 | Cancer Control | 4.3 | 52nd | Q2 | SCIE | – | Yes |
| 203 | Hereditary Cancer in Clinical Practice | 4.3 | 52nd | Q2 | SCIE | – | Yes |
| 204 | Current Cancer Drug Targets | 4.2 | 52nd | Q2 | SCIE | – | No |
| 205 | International Journal of Breast Cancer | 4.2 | 52nd | Q2 | ESCI | – | Yes |
| 206 | Advances in Radiation Oncology | 4.2 | 51st | Q2 | ESCI | – | Yes |
| 207 | Breast Care | 4.2 | 51st | Q2 | SCIE | – | No |
| 208 | Hematology/ Oncology and Stem Cell Therapy | 4.2 | 51st | Q2 | – | – | Yes |
| 209 | Immunotherapy | 4.2 | 51st | Q2 | SCIE | – | No |
| 210 | Oncology Research | 4.1 | 51st | Q2 | SCIE | – | No |
| 211 | Asia-Pacific Journal of Oncology Nursing | 4.1 | 50th | Q2 | SCIE, SSCI | – | Yes |
| 212 | International Journal of Biological Markers | 4.1 | 50th | Q2 | SCIE | – | Yes |
| 213 | JMIR Cancer | 4.1 | 50th | Q2 | ESCI | – | Yes |
| 214 | Leukemia Research | 4.1 | 50th | Q2 | SCIE | – | No |
| 215 | Journal of Chemotherapy | 4.1 | 49th | Q3 | SCIE | – | No |
| 216 | Cancer Causes and Control | 4 | 49th | Q3 | SCIE | – | No |
| 217 | Clinical Genitourinary Cancer | 4 | 49th | Q3 | SCIE | – | No |
| 218 | Tumori | 4 | 49th | Q3 | SCIE | – | No |
| 219 | Chinese Journal of Oncology | 4 | 48th | Q3 | – | – | No |
| 220 | Journal of Cancer Education | 4 | 48th | Q3 | SCIE | – | No |
| 221 | Acta Oncologica | 3.9 | 48th | Q3 | SCIE | – | Yes |
| 222 | Journal of the National Cancer Institute - Monographs | 3.9 | 48th | Q3 | – | – | No |
| 223 | Pediatric Blood and Cancer | 3.9 | 48th | Q3 | SCIE | – | No |
| 224 | Asia-Pacific Journal of Clinical Oncology | 3.9 | 47th | Q3 | SCIE | – | No |
| 225 | Leukemia and Lymphoma | 3.9 | 47th | Q3 | SCIE | – | No |
| 226 | Brain Tumor Research and Treatment | 3.8 | 47th | Q3 | – | – | No |
| 227 | Cardio-Oncology | 3.8 | 47th | Q3 | ESCI | – | Yes |
| 228 | Cancer Investigation | 3.7 | 46th | Q3 | SCIE | – | No |
| 229 | Journal of Hepatocellular Carcinoma | 3.7 | 46th | Q3 | SCIE | – | Yes |
| 230 | Journal of Liquid Biopsy | 3.7 | 46th | Q3 | ESCI | – | Yes |
| 231 | Radiology and Oncology | 3.7 | 46th | Q3 | SCIE | – | Yes |
| 232 | Cancer Reports | 3.7 | 45th | Q3 | ESCI | – | Yes |
| 233 | Familial Cancer | 3.7 | 45th | Q3 | SCIE | – | No |
| 234 | Journal of Surgical Oncology | 3.7 | 45th | Q3 | SCIE | – | No |
| 235 | Oncology Letters | 3.7 | 45th | Q3 | SCIE | – | No |
| 236 | Japanese Journal of Clinical Oncology | 3.7 | 44th | Q3 | SCIE | – | No |
| 237 | Chemotherapy | 3.6 | 44th | Q3 | SCIE | – | No |
| 238 | Journal of Gastrointestinal Oncology | 3.6 | 44th | Q3 | SCIE | – | No |
| 239 | Journal of Psychosocial Oncology | 3.6 | 44th | Q3 | SSCI | – | No |
| 240 | Radiation Oncology Journal | 3.6 | 44th | Q3 | ESCI | – | No |
| 241 | Breast Journal | 3.6 | 43rd | Q3 | SCIE | – | Yes |
| 242 | Clinical Medicine Insights: Oncology | 3.5 | 43rd | Q3 | SCIE | – | Yes |
| 243 | Oncology (Switzerland) | 3.5 | 43rd | Q3 | SCIE | – | No |
| 244 | World Journal of Oncology | 3.5 | 43rd | Q3 | ESCI | – | No |
| 245 | Breast Cancer: Basic and Clinical Research | 3.4 | 42nd | Q3 | ESCI | – | Yes |
| 246 | Chinese Clinical Oncology | 3.4 | 42nd | Q3 | ESCI | – | No |
| 247 | Journal of Gastrointestinal Cancer | 3.4 | 42nd | Q3 | ESCI | – | No |
| 248 | Translational Breast Cancer Research | 3.4 | 42nd | Q3 | ESCI | – | No |
| 249 | Anticancer Research | 3.4 | 41st | Q3 | SCIE | – | No |
| 250 | Current Opinion in Supportive and Palliative Care | 3.4 | 41st | Q3 | SCIE | – | No |
| 251 | International Journal of Women's Health | 3.4 | 41st | Q3 | SCIE | – | Yes |
| 252 | Oral Oncology Reports | 3.4 | 41st | Q3 | – | – | Yes |
| 253 | Journal of the Egyptian National Cancer Institute | 3.2 | 41st | Q3 | ESCI | – | Yes |
| 254 | World Journal of Gastrointestinal Oncology | 3.2 | 40th | Q3 | SCIE | – | No |
| 255 | Journal of Adolescent and Young Adult Oncology | 3.1 | 40th | Q3 | SCIE | – | No |
| 256 | Melanoma Research | 3.1 | 40th | Q3 | SCIE | – | No |
| 257 | Oncologie | 3.1 | 40th | Q3 | SCIE | – | Yes |
| 258 | Asian Pacific Journal of Cancer Prevention | 3.1 | 39th | Q3 | – | – | Yes |
| 259 | Cancer/Radiotherapie | 3.1 | 39th | Q3 | SCIE | – | No |
| 260 | European Journal of Breast Health | 3 | 39th | Q3 | ESCI | – | Yes |
| 261 | Journal of Medical Imaging and Radiation Oncology | 3 | 39th | Q3 | SCIE | – | No |
| 262 | Hepatoma Research | 3 | 38th | Q3 | ESCI | – | No |
| 263 | Molecular and Clinical Oncology | 3 | 38th | Q3 | ESCI | – | No |
| 264 | Journal of Skin Cancer | 2.9 | 38th | Q3 | ESCI | – | Yes |
| 265 | Mediastinum | 2.9 | 38th | Q3 | ESCI | – | No |
| 266 | Journal of Cancer Policy | 2.9 | 37th | Q3 | ESCI | – | No |
| 267 | BJUI Compass | 2.8 | 37th | Q3 | ESCI | – | Yes |
| 268 | Brachytherapy | 2.8 | 37th | Q3 | SCIE | – | No |
| 269 | Reports of Practical Oncology and Radiotherapy | 2.8 | 37th | Q3 | ESCI | – | Yes |
| 270 | Oncology (United States) | 2.7 | 37th | Q3 | SCIE | – | No |
| 271 | American Journal of Clinical Oncology: Cancer Clinical Trials | 2.7 | 36th | Q3 | SCIE | – | No |
| 272 | Journal of Oncology Pharmacy Practice | 2.7 | 36th | Q3 | SCIE | – | No |
| 273 | Biophysics Reports | 2.6 | 36th | Q3 | – | – | Yes |
| 274 | Clinical Lymphoma, Myeloma and Leukemia | 2.6 | 36th | Q3 | SCIE | – | No |
| 275 | Translational Cancer Research | 2.6 | 35th | Q3 | SCIE | – | No |
| 276 | Breast Disease | 2.5 | 35th | Q3 | – | – | No |
| 277 | Cancer Diagnosis and Prognosis | 2.5 | 35th | Q3 | – | – | No |
| 278 | Precision Cancer Medicine | 2.5 | 35th | Q3 | – | – | No |
| 279 | Journal of Contemporary Brachytherapy | 2.4 | 34th | Q3 | SCIE | – | Yes |
| 280 | Medical Dosimetry | 2.4 | 34th | Q3 | SCIE | – | No |
| 281 | Oncology Research and Treatment | 2.4 | 34th | Q3 | SCIE | – | No |
| 282 | Wspolczesna Onkologia | 2.4 | 34th | Q3 | ESCI | – | Yes |
| 283 | Cancer Treatment and Research | 2.3 | 33rd | Q3 | – | – | No |
| 284 | Current Urology | 2.3 | 33rd | Q3 | ESCI | – | Yes |
| 285 | Journal of Cancer Research and Therapeutics | 2.3 | 33rd | Q3 | SCIE | – | No |
| 286 | Pediatric Hematology and Oncology | 2.3 | 33rd | Q3 | SCIE | – | No |
| 287 | Lung Cancer Management | 2.2 | 33rd | Q3 | ESCI | – | No |
| 288 | Dermatology Practical and Conceptual | 2.2 | 32nd | Q3 | SCIE | – | Yes |
| 289 | EJC Paediatric Oncology | 2.2 | 32nd | Q3 | ESCI | – | Yes |
| 290 | Bladder Cancer | 2.1 | 32nd | Q3 | SCIE | – | Yes |
| 291 | ecancermedicalscience | 2.1 | 32nd | Q3 | ESCI | – | Yes |
| 292 | Gastrointestinal Disorders | 2.1 | 31st | Q3 | ESCI | – | Yes |
| 293 | Prostate Cancer | 2.1 | 31st | Q3 | ESCI | – | Yes |
| 294 | Gynecologic Oncology Reports | 2 | 31st | Q3 | ESCI | – | Yes |
| 295 | Onco | 2 | 31st | Q3 | ESCI | – | Yes |
| 296 | Holistic Integrative Oncology | 2 | 30th | Q3 | – | – | Yes |
| 297 | Asian Pacific Journal of Cancer Biology | 1.9 | 30th | Q3 | – | – | Yes |
| 298 | Discover Oncology | 1.9 | 30th | Q3 | SCIE | – | Yes |
| 299 | Journal of Cancer Metastasis and Treatment | 1.9 | 30th | Q3 | ESCI | – | No |
| 300 | Journal of Pediatric Hematology/Oncology | 1.8 | 30th | Q3 | SCIE | – | No |
All remaining Oncology journals (128)
Ranked below the top 300 by CiteScore percentile. Every title links to its full profile.
- Hepatic Oncology Q3
- Kidney Cancer Q3
- Bulletin du Cancer Q3
- Chinese Journal of Lung Cancer Q3
- Leukemia Research Reports Q3
- Rare Tumors Q3
- Recent Results in Cancer Research Q3
- World Cancer Research Journal Q3
- Breast Cancer Management Q3
- Current Breast Cancer Reports Q3
- Indian Journal of Cancer Q3
- Iranian Journal of Blood and Cancer Q3
- Clinical Journal of Oncology Nursing Q3
- Nowotwory Q3
- Experimental Oncology Q3
- Current Cancer Therapy Reviews Q3
- Foregut Q3
- Clinical Advances in Hematology and Oncology Q3
- Indian Journal of Surgical Oncology Q3
- Oncology and Translational Medicine Q3
- Frontiers in Hematology Q3
- Acta Haematologica Polonica Q4
- Case Reports in Oncology Q4
- Melanoma Management Q4
- Memo - Magazine of European Medical Oncology Q4
- Annals of Research in Oncology Q4
- Archives of Breast Cancer Q4
- Blood Neoplasia Q4
- Journal of Radiotherapy in Practice Q4
- Pediatric Hematology Oncology Journal Q4
- European Journal of Oncology Pharmacy Q4
- Iranian Journal of Breast Diseases Q4
- Koloproktologia Q4
- Rehabilitation Oncology Q4
- Eurasian Journal of Medicine and Oncology Q4
- China Oncology Q4
- International Journal of Hematology-Oncology and Stem Cell Research Q4
- South Asian Journal of Cancer Q4
- Journal of Obstetrics, Gynecology and Cancer Research Q4
- Klinicka Onkologie Q4
- Oncology in Clinical Practice Q4
- Therapeutic Radiology and Oncology Q4
- Endocrine Oncology Q4
- Indian Journal of Medical and Paediatric Oncology Q4
- International Journal of Cancer Management Q4
- Middle East Journal of Cancer Q4
- Surgical Oncology Insight Q4
- Annals of Cancer Research and Therapy Q4
- Iranian Journal of Pediatric Hematology and Oncology Q4
- NTP Technical Report on the Toxicity Studies Series Q4
- Russian Journal of Woman and Child Health Q4
- Annals of Pancreatic Cancer Q4
- Asian Pacific Journal of Cancer Care Q4
- Healthbook TIMES Oncology Hematology Q4
- Travmatologiya i Ortopediya Rossii Q4
- Blood Vessels, Thrombosis and Hemostasis Q4
- EJC Skin Cancer Q4
- Indian Journal of Gynecologic Oncology Q4
- Magyar Onkologia Q4
- Sechenov Medical Journal Q4
- Klinicheskaya Onkogematologiya/Clinical Oncohematology Q4
- Pediatric Hematology/Oncology and Immunopathology Q4
- Siberian Journal of Oncology Q4
- Trends in Immunotherapy Q4
- Journal of Modern Oncology Q4
- Medecine Palliative Q4
- Oncogematologiya Q4
- Opuholi Zenskoj Reproduktivnoj Sistemy Q4
- Current Problems in Cancer: Case Reports Q4
- European Oncology and Haematology Q4
- Journal of Cancer Research Updates Q4
- Psicooncologia Q4
- Voprosy Onkologii Q4
- Cancer Drug Discovery and Development Q4
- Opuholi Golovy i Sei Q4
- Revista de Senologia y Patologia Mamaria Q4
- Turk Onkoloji Dergisi Q4
- Khirurgiya i Onkologiya Q4
- Chinese Journal of Cancer Prevention and Treatment Q4
- Russian Journal of Immunology Q4
- Ukrainian Journal of Radiology and Oncology Q4
- Experimed Q4
- Health of Man Q4
- Indonesian Journal of Obstetrics and Gynecology Q4
- Journal of Cancer Rehabilitation Q4
- Chinese Journal of Radiation Oncology Q4
- Hematology in Clinical Practice Q4
- Onkourologiya Q4
- Russian Journal of Pediatric Hematology and Oncology Q4
- Cancer Research on Prevention and Treatment Q4
- Journal of Head and Neck Physicians and Surgeons Q4
- Libri Oncologici Q4
- Rossijskij Bioterapevticeskij Zurnal Q4
- Forum of Clinical Oncology Q4
- Journal of Practical Oncology Q4
- Onkologie Q4
- P.A. Herzen Journal of Oncology Q4
- Sarkomy Kostej, Magkih Tkanej i Opuholi Kozi Q4
- Cancer and Chemotherapy Reviews Q4
- European Journal of Oncology Q4
- International Journal of Gastrointestinal Intervention Q4
- Onkologia i Radioterapia Q4
- Archive of Oncology Q4
- Chinese Journal of Clinical Oncology Q4
- Gaceta Mexicana de Oncologia Q4
- Journal of Oncological Science Q4
- Permskij Medicinskij Zurnal Q4
- Pediatric Oncology Q4
- Surgery, Gastroenterology and Oncology Q4
- Tumor Q4
- UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi Q4
- Onkologija Q4
- Eurasian Journal of Oncology Q4
- Hepato-Gastro et Oncologie Digestive Q4
- Japanese Journal of Cancer and Chemotherapy Q4
- Best Practice Onkologie Q4
- Cancer Research and Clinic Q4
- Chinese Journal of Aerospace Medicine Q4
- Journal of Leukemia and Lymphoma Q4
- Japanese Journal of Lung Cancer Q4
- Revista Venezolana de Oncologia Q4
- Hematology Transfusiology Eastern Europe Q4
- Onkologie (Czech Republic) Q4
- Tumor Diagnostik und Therapie Q4
- Advanced Spine Journal Q4
- Japanese Journal of Head and Neck Cancer Q4
- Journal of B.U.ON. Q4
- Revisiones en Cancer Q4
Rank and percentile are within the Oncology Scopus subject table (CiteScore 2025, dataset 2026-10-04). A journal can rank differently in its other subject areas — open its profile for the full picture.